The closure of a massive AstraZeneca drug manufacturing facility in Westboro next year is an outlier and doesn't signal trouble in the state's booming life sciences industry, one local industry watcher said.
"That particular facility and the kind of manufacturing they did there is somewhat of an outlier," said Peter Abair, director of economic development and global affairs for the Massachusetts Biotechnology Council. "It's the type of manufacturing we don't really do a lot, it's more traditional pharmaceutical inhalants."
Yesterday, the drug giant said it will close its manufacturing facility in Westboro in late 2015, affecting roughly 180 employees and contractors. The facility makes Pulmicort Respules, an asthma treatment.
The biotech boom in Massachusetts is built largely on biologic drugs — treatments based on living organisms. That manufacturing process is still advancing incredibly quickly, "on a daily basis," Abair said. Because of that, companies are keeping their research and manufacturing close, he said.
Anda sedang membaca artikel tentang
AstraZeneca to shut Westboro plant
Dengan url
http://wartawanlocal.blogspot.com/2014/12/astrazeneca-to-shut-westboro-plant.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
AstraZeneca to shut Westboro plant
namun jangan lupa untuk meletakkan link
AstraZeneca to shut Westboro plant
sebagai sumbernya
0 komentar:
Posting Komentar